Drug Type Small molecule drug |
Synonyms KBP-7909 |
Target |
Action inhibitors |
Mechanism LpxC inhibitors(UDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Gram-Negative Bacterial Infections | Preclinical | China | - |





